SPY326.54-3.44 -1.04%
DIA265.06-1.53 -0.57%
IXIC10,911.59-274.00 -2.45%

Cantor Fitzgerald Downgrades Intercept Pharmaceuticals to Neutral

Cantor Fitzgerald analyst Alethia Young downgrades Intercept Pharmaceuticals (NASDAQ:ICPT) from Overweight to Neutral.

Benzinga · 06/30/2020 10:33
Cantor Fitzgerald analyst Alethia Young downgrades Intercept Pharmaceuticals (NASDAQ: ICPT) from Overweight to Neutral.